Target intelligence / Profile preview

PARG pseudogene 1 (PARGP1)

Target
PARGP1
Molecular classification
Other (pseudogene)
01

Overview

PARGP1 stands for “PARG pseudogene 1,” referring to a non-functional genomic locus that is similar in sequence to the protein-coding Poly(ADP-ribose) glycohydrolase (PARG) gene. Pseudogenes, by definition, are segments of DNA that resemble known genes but contain mutations or sequence interruptions that typically prevent them from producing a functional protein. While some pseudogenes or their RNA products can have regulatory roles, there is no current evidence or established knowledge linking PARGP1 to any biological function, disease, or therapeutic process. It is not a recognized therapeutic target or biomarker[3][4][6]. PARGP1 is best described as a pseudogene and not a molecular or therapeutic target. There is no evidence supporting its relevance as a biomarker, drug target, or disease-associated locus. It is likely included in error if referenced in the context of drug discovery or clinical development.

Other names
PARGP1poly(ADP-ribose) glycohydrolase pseudogene 1
02

Biological functions

Other (no confirmed function; pseudogenes do not encode functional proteins, though some pseudogene transcripts can play regulatory roles)
03

Disease associations

Other (no evidence directly links PARGP1 to diseases; some pseudogenes are studied for possible regulatory effects in cancer or other diseases, but not specifically for PARGP1)

Beyond the preview

Go deeper on PARG pseudogene 1 (PARGP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PARG pseudogene 1 (PARGP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call